Akers Biosciences, Inc.
|Number of Estimates|
Akers Biosciences, Inc. develops health information technologies. It engages in the developing, manufacturing, and supplying screening and testing products to deliver healthcare information to consumers and healthcare providers. Its products include clinical diagnostics, safety diagnostics, wellness products, and tests in development. The company was founded by Raymond Francis Akers, Jr. and Raymond F. Akers, Sr. on March 8, 1989 and is headquartered in West Deptford, NJ.
Market Cap: 3.36 Million
Primary Exchange: NASDAQ
Shares Outstanding: 12.5 Million
Float: 12.5 Million
Sector: Health Technology
Industry: Medical Specialties
Longest drawdown: 1991 trading days
From: 2013-10-21 To: 2019-11-19
|Ex-Date||Payment Date||Record Date||Declared Date||Amount||Flag||Dividend Type||Qualified||Indicated|
|Ex-Date||Declared Date||Record Date||Payment Date||Ratio||To Factor||For Factor|